Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

PRISM MEDICO AND PHARMACY LTD. - 512217 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Dear Sir/Madam, Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 we hereby furnish the confirmation certificate issued by the Registrar and Share Transfer Agent (RTA) for the quarter ended 31st March, 2024. You are requested to kindly take the same on your record and acknowledge receipt. Thanking You.
13-04-2024
Bigul

PRISM MEDICO AND PHARMACY LTD. - 512217 - Intimation Under Regulation 57(4) Of SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015.

 Dear Sir/Madam, Pursuant to Regulation 57(4) of SEBI (LODR) Regulations, 2015 it is informed that the company has not issued any non-convertible securities for which interest/dividend/principal amount shall be payable during the quarter beginning 01st April, 2024 and ending on 30th June, 2024. You are requested to kindly take the same on record and acknowledge the receipt. Thanking You.
01-04-2024
Bigul

PRISM MEDICO AND PHARMACY LTD. - 512217 - Compliance-57 (5) : intimation after the end of quarter

 Dear Sir/Madam, Pursuant to Regulation 57(5) of SEBI (LODR) Regulations, 2015, we hereby confirm that the company has not issued any non-convertible securities. Therefore, there were no interest/dividend/principal obligations which were due for payment during the quarter beginning 01st January, 2024 and ended on 31st March, 2024. You are requested to kindly take the same on record and acknowledge receipt. Thanking You.
01-04-2024
Bigul

PRISM MEDICO AND PHARMACY LTD. - 512217 - Closure of Trading Window

 Dear Sir/Madam, Pursuant to Code of Conduct to regulate, monitor and report Trading by insiders ("Code") and applicable SEBI Regulations, we would like to inform you that trading window for dealing in the securities of the company by insiders stands closed from 01st April, 2024 and will be re-opened 48 hours after the declaration of financial results for the financial and quarter ended 31st March, 2024 to the stock exchanges. You are requested to kindly take the same on your record and acknowledge receipt. Thanking you.
01-04-2024
Bigul

PRISM MEDICO AND PHARMACY LTD. - 512217 - Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The Securities Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.

 Dear Sir/Madam, Pursuant to Regulation 30 of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors of the company at their meeting held today (i.e. 13th February, 2024) which commenced at 03:00 P.M. and concluded at 04:00 P.M. have inter alia approved the following: ? The Board considered and approved the Unaudited Standalone Financial Results of the company for the quarter ended 31st December, 2023 alongwith the Limited Review Report duly signed by the Auditors of the company. You are requested to kindly take the same on record and oblige. Thanking You.
13-02-2024
Bigul

PRISM MEDICO AND PHARMACY LTD. - 512217 - Board Meeting Intimation for Intimation Of Board Meeting.

 PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 ,inter alia, to consider and approve Dear Sir/Madam, With reference to the captioned subject and in compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that the meeting of the Board of Directors of M/s. Prism Medico and Pharmacy Limited (hereinafter referred as 'the Company') is scheduled to be held at the registered office of the company i.e. Suketi Road, Kala Amb, Sirmaur, Himachal Pradesh-173030 on Tuesday, the 13th day of February, 2024 at 03:00 P.M. inter alia, to: - Consider, approve and take on record the Unaudited Standalone Financial Results of the company along with the Limited Review Report for the quarter ended 31st December, 2023, as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. - Consider and discuss any other routine matter or business of the company. You are requested to kindly take the same on your record and acknowledge receipt. Thanking You.
05-02-2024
Bigul

PRISM MEDICO AND PHARMACY LTD. - 512217 - Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.

 Dear Sir/Madam, Please find the attached report on investor complaints for the quarter ended 31st December, 2023. Thanking You.
19-01-2024
Bigul

PRISM MEDICO AND PHARMACY LTD. - 512217 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Dear Sir/Madam, Please find the attached certificate issued by the Registrar and Share Transfer Agent (RTA) for the quarter ended 31st December, 2023. Thanking You.
15-01-2024
Bigul

PRISM MEDICO AND PHARMACY LTD. - 512217 - Compliance-57 (5) : intimation after the end of quarter

 Dear Sir/Madam, With reference to the captioned subject please find attached herewith intimation under Regulation 57(5) of SEBI (LODR) Regulations, 2015 for the quarter ended 01st October, 2023 to 31st December, 2023. Thanking You.
05-01-2024
Bigul

PRISM MEDICO AND PHARMACY LTD. - 512217 - Intimation Under Regulation 57(4) Of SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015.

 Dear Sir/Madam, With reference to the captioned subject please find attached herewith intimation under Regulation 57(4) of SEBI (LODR) Regulations, 2015 for the quarter beginning 01st January, 2024 to 31st March, 2024. Thanking You.
05-01-2024
Next Page
Close

Let's Open Free Demat Account